MOTS-C Reconstitution Chart (Every Vial Size)

Overview of Lyophilized MOTS-C in Preclinical Assays

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino-acid mitochondrial-derived peptide studied extensively for its role in cellular energy balance, metabolic regulation, and exercise-capacity research. Preclinical research indicates that this microprotein translocates to the nucleus under metabolic stress to regulate nuclear gene expression and activate 5'-AMP-activated protein kinase (AMPK). Due to its peptide structure, solid-phase synthesis yields a freeze-dried (lyophilized) cake that requires controlled reconstitution prior to administration in vitro or in rodent models.

To preserve the structural integrity of MOTS-c and guarantee experimental reproducibility, investigators must adhere to strict volumetric standards. Improper solvent selection or volumetric inaccuracies alter molecular aggregation states, impacting bioavailability in cell cultures and animal models. Every lot supplied by PX1 Research undergoes strict analytical testing, featuring a lot-specific COA verifying HPLC purity (>99%), mass spectrometry mass identity, and low endotoxin levels prior to laboratory dispatch.

Master MOTS-C Reconstitution Reference Table

The following reference matrix provides exact concentrations (mg/mL) and mass yields per 0.1 mL (100 µL laboratory volume) across common lyophilized vial capacities (2 mg, 5 mg, 10 mg) and target diluent additions (1.0 mL, 2.0 mL, 2.5 mL, 3.0 mL).

| Vial Size (Mass) | Diluent Volume Added | Resulting Concentration (mg/mL) | Yield per 0.1 mL (100 µL) | |---|---|---|---| | 2.0 mg | 1.0 mL | 2.0 mg/mL | 0.20 mg (200 µg) | | 2.0 mg | 2.0 mL | 1.0 mg/mL | 0.10 mg (100 µg) | | 2.0 mg | 3.0 mL | 0.67 mg/mL | 0.067 mg (67 µg) | | 5.0 mg | 1.0 mL | 5.0 mg/mL | 0.50 mg (500 µg) | | 5.0 mg | 2.0 mL | 2.5 mg/mL | 0.25 mg (250 µg) | | 5.0 mg | 2.5 mL | 2.0 mg/mL | 0.20 mg (200 µg) | | 5.0 mg | 3.0 mL | 1.67 mg/mL | 0.167 mg (167 µg) | | 10.0 mg | 1.0 mL | 10.0 mg/mL | 1.00 mg (1000 µg) | | 10.0 mg | 2.0 mL | 5.0 mg/mL | 0.50 mg (500 µg) | | 10.0 mg | 2.5 mL | 4.0 mg/mL | 0.40 mg (400 µg) | | 10.0 mg | 3.0 mL | 3.33 mg/mL | 0.333 mg (333 µg) |

When preparing stock solutions for high-throughput in vitro screening or systemic administration in rodent models, researchers should choose diluent volumes that balance solubility limits with volumetric precision. For automated liquid handling systems, higher dilution volumes (e.g., 2.5 mL to 3.0 mL) reduce margin of error during micro-pipetting.

Mathematical Formulas and Worked Calculation Examples

Calculating target concentrations for custom vial masses or non-standard diluent volumes requires basic volumetric principles. The general formula for determining concentration ($C$) based on total peptide mass ($M$) and added diluent volume ($V$) is defined as:

$$C = \frac{M}{V}$$

Where $C$ represents the final concentration in milligrams per milliliter (mg/mL), $M$ is the lyophilized mass in milligrams (mg), and $V$ is the diluent volume in milliliters (mL). To determine the peptide mass present in a specific assay volume ($V_{assay}$), use the equation:

$$\text{Mass}_{assay} = C \times V_{assay}$$

**Worked Example 1:** A researcher reconstitutes a 5 mg vial of MOTS-C with 2.0 mL of bacteriostatic 0.9% sodium chloride injection. Utilizing the concentration equation: $C = 5.0\text{ mg} / 2.0\text{ mL} = 2.5\text{ mg/mL}$. If the experimental protocol mandates an in vitro treat volume of 0.05 mL (50 µL) per culture well, the absolute mass delivered per well is calculated as: $2.5\text{ mg/mL} \times 0.05\text{ mL} = 0.125\text{ mg}$ (or 125 µg).

**Worked Example 2:** An investigator working with a 10 mg vial of MOTS-c requires a stock concentration yielding exactly 0.4 mg per 0.1 mL aliquot. To solve for necessary diluent volume ($V$): $V = M / C$. Since the desired concentration is $0.4\text{ mg} / 0.1\text{ mL} = 4.0\text{ mg/mL}$, the required diluent volume is $V = 10.0\text{ mg} / 4.0\text{ mg/mL} = 2.5\text{ mL}$. To streamline these calculations during laboratory preparation, researchers can utilize the online interactive reconstitution calculator.

Selecting Compatible Diluents for Laboratory Applications

Choosing the appropriate reconstitution solvent depends directly on the downstream experimental assay, storage duration, and biological system under investigation. Lyophilized MOTS-c exhibits excellent solubility in aqueous buffer systems, but solvent choice directly affects long-term molecular stability.

Bacteriostatic Water (0.9% Benzyl Alcohol): Recommended for multi-dose preclinical rodent studies extending over several days. The inclusion of 0.9% benzyl alcohol inhibits microbial proliferation when vials are repeatedly accessed under aseptic conditions in standard laboratory settings. Store reconstituted stock at 2–8°C.

Sterile 0.9% Sodium Chloride (Normal Saline): Preferred for acute in vivo rodent administration or short-term metabolic challenge assays. Normal saline provides physiological osmolarity, preventing osmotic shock to tissues. However, saline stock solutions lacking preservatives must be used immediately or aliquoted and frozen to prevent microbial growth.

Phosphate-Buffered Saline (PBS, pH 7.4): Ideal for direct addition to cell culture media in in vitro assays. PBS maintains physiological pH and ion concentration. When reconstituting in PBS, filter-sterilize the final solution through a 0.22 µm PES membrane if sterile conditions are required for extended cell culture experiments.

Step-by-Step Aseptic Reconstitution Protocol

To maintain lot purity, prevent bacterial contamination, and prevent physical shear degradation of the MOTS-c peptide chain, observe the following standard operating protocol inside a certified laminar flow hood:

1. **Equilibration:** Remove the lyophilized MOTS-c vial from cold storage (-20°C or -80°C) and allow it to reach ambient room temperature (20–25°C) before reconstitution. Opening cold vials exposes the dry cake to atmospheric condensation, which can induce rapid hydrolytic degradation.

2. **Sanitization:** Clean the rubber septum of the peptide vial and the diluent vial using a 70% isopropyl alcohol wipe. Allow the surfaces to air dry completely.

3. **Diluent Withdrawal:** Using a sterile, single-use syringe fitted with a 21G–25G needle, draw the exact volume of diluent indicated by your experimental design (e.g., 2.0 mL).

4. **Controlled Injection:** Depress the needle through the center of the rubber stopper at a 45-degree angle. Direct the stream of diluent down the glass inner wall of the vial rather than shooting it directly onto the lyophilized powder mass. This gentle wetting prevents structural shearing of the peptide.

5. **Pressure Equalization:** Equalize positive internal pressure inside the vial by pulling back on the syringe plunger to withdraw an air volume equivalent to the introduced liquid volume prior to removing the needle.

6. **Dissolution:** Allow the diluent to fully saturate the powder. Gently swirl the vial in a circular motion. **Never shake the vial**, as vigorous agitation introduces air bubbles and denatures secondary peptide structures.

Storage, Aliquoting, and Stability Parameters

Lyophilized MOTS-c exhibits superior chemical stability when stored at -20°C or lower in a frost-free freezer, protected from direct light exposure. Under these conditions, unopened vials sourced from PX1 Research retain full potency across extended storage intervals.

Once reconstituted, aqueous MOTS-c solutions undergo gradual hydrolytic degradation. Reconstituted stock solutions prepared with bacteriostatic water remain stable at 2–8°C for up to 14 days. If the experimental timeline exceeds this window, researchers should immediately aliquot the stock into single-use polypropylene microtubes and store them at -80°C. Repeated freeze-thaw cycles must be strictly avoided, as thermal cycling causes molecular aggregation and structural breakdown. Browse our catalog of research compounds across all peptides for complementary metabolic markers.

Comparative Analysis: MOTS-C vs. Related Metabolic Research Compounds

In metabolic regulation and mitochondrial performance research, MOTS-c is frequently evaluated alongside other targeted peptides and small molecules to map overlapping signaling cascades. Understanding how MOTS-c compares to other candidates helps researchers build comprehensive multi-target trial designs.

For example, SS-31 (Elamipretide) targets inner mitochondrial membrane cardiolipin to restore electron transport chain efficiency and reduce reactive oxygen species (ROS). Conversely, MOTS-c acts primarily as a signaling messenger that translocates to the nucleus to induce broad transcriptional responses and activate AMPK. Meanwhile, Humanin—another mitochondria-derived peptide—exhibits cytoprotective and anti-apoptotic properties across neurodegenerative and metabolic research models. Researchers exploring broad metabolic flux may also cross-reference small-molecule activators like AICAR to evaluate synergistic activation of downstream metabolic targets.

Preclinical Applications in Metabolic and Exercise Research

In vitro data indicate that MOTS-c regulates metabolic homeostasis by directly targeting skeletal muscle and liver tissue pathways. In cell culture models, application of reconstituted MOTS-c enhances glucose uptake via GLUT4 translocation independently of classical insulin receptor signaling cascades.

In rodent models, animal studies demonstrate that systemic administration of MOTS-c enhances physical performance, increases oxygen consumption, and prevents high-fat diet-induced insulin resistance. Researchers monitoring mitochondrial biogenesis measure expression markers such as PGC-1α and TFAM following MOTS-c exposure. Achieving accurate reconstitution ratios ensures that dosing in rodent models (typically measured in mg/kg body mass) remains precise and reproducible across cohort groups.

PX1 Research Quality Assurance and Analytical Benchmarks

PX1 Research manufactures peptides specifically for rigorous laboratory and analytical applications. Every batch of MOTS-c is synthesized in state-of-the-art, GMP-compliant facilities in the United States and validated by independent ISO 17025 accredited testing laboratories.

Our quality verification process incorporates High-Performance Liquid Chromatography (HPLC) to confirm purity exceeding 99% and Mass Spectrometry (MS) to verify precise molecular weight. Furthermore, all lots undergo kinetic chromogenic LAL assays to ensure endotoxin levels remain strictly below <0.01 EU/mg, minimizing confounding inflammatory responses in sensitive cell cultures or animal models. To explore institutional purchasing or setup laboratory accounts, visit our wholesale portal or search the research library for additional technical documentation.